These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 38338806)
41. Moesin-ezrin-radixin-like protein (merlin) mediates protein interacting with the carboxyl terminus-1 (PICT-1)-induced growth inhibition of glioblastoma cells in the nucleus. Chen H; Mei L; Zhou L; Zhang X; Guo C; Li J; Wang H; Zhu Y; Zheng Y; Huang L Int J Biochem Cell Biol; 2011 Apr; 43(4):545-55. PubMed ID: 21167305 [TBL] [Abstract][Full Text] [Related]
42. Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity. Laulajainen M; Melikova M; Muranen T; Carpén O; Grönholm M J Cell Mol Med; 2012 Sep; 16(9):2161-75. PubMed ID: 22325036 [TBL] [Abstract][Full Text] [Related]
43. Analysis of RAS and drug induced homo- and heterodimerization of RAF and KSR1 proteins in living cells using split Nanoluc luciferase. Rohrer L; Spohr C; Beha C; Griffin R; Braun S; Halbach S; Brummer T Cell Commun Signal; 2023 Jun; 21(1):136. PubMed ID: 37316874 [TBL] [Abstract][Full Text] [Related]
44. Nucleocytoplasmic transfer of the NF2 tumor suppressor protein merlin is regulated by exon 2 and a CRM1-dependent nuclear export signal in exon 15. Kressel M; Schmucker B Hum Mol Genet; 2002 Sep; 11(19):2269-78. PubMed ID: 12217955 [TBL] [Abstract][Full Text] [Related]
45. Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation. Sekido Y Pathol Int; 2011 Jun; 61(6):331-44. PubMed ID: 21615608 [TBL] [Abstract][Full Text] [Related]
46. Compensative shuttling of merlin to phosphorylation on serine 518 in vestibular schwannoma. Lü J; Zou J; Wu H; Cai L Laryngoscope; 2008 Jan; 118(1):169-74. PubMed ID: 17989580 [TBL] [Abstract][Full Text] [Related]
47. Two Sides of the Coin: Ezrin/Radixin/Moesin and Merlin Control Membrane Structure and Contact Inhibition. Michie KA; Bermeister A; Robertson NO; Goodchild SC; Curmi PMG Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018575 [TBL] [Abstract][Full Text] [Related]
48. Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L. Rong R; Tang X; Gutmann DH; Ye K Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18200-5. PubMed ID: 15598747 [TBL] [Abstract][Full Text] [Related]
49. β1 integrin-dependent Rac/group I PAK signaling mediates YAP activation of Yes-associated protein 1 (YAP1) via NF2/merlin. Sabra H; Brunner M; Mandati V; Wehrle-Haller B; Lallemand D; Ribba AS; Chevalier G; Guardiola P; Block MR; Bouvard D J Biol Chem; 2017 Nov; 292(47):19179-19197. PubMed ID: 28972170 [TBL] [Abstract][Full Text] [Related]
50. Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival. Stamenkovic I; Yu Q Curr Protein Pept Sci; 2010 Sep; 11(6):471-84. PubMed ID: 20491622 [TBL] [Abstract][Full Text] [Related]
51. Identification and characterization of putative tumor suppressor NGB, a GTP-binding protein that interacts with the neurofibromatosis 2 protein. Lee H; Kim D; Dan HC; Wu EL; Gritsko TM; Cao C; Nicosia SV; Golemis EA; Liu W; Coppola D; Brem SS; Testa JR; Cheng JQ Mol Cell Biol; 2007 Mar; 27(6):2103-19. PubMed ID: 17210637 [TBL] [Abstract][Full Text] [Related]
52. Merlin tumor suppressor function is regulated by PIP2-mediated dimerization. Hennigan RF; Thomson CS; Stachowski K; Nassar N; Ratner N PLoS One; 2023; 18(2):e0281876. PubMed ID: 36809290 [TBL] [Abstract][Full Text] [Related]
53. Regulation of the neurofibromatosis type 2 tumor suppressor protein, merlin, by adhesion and growth arrest stimuli. Shaw RJ; McClatchey AI; Jacks T J Biol Chem; 1998 Mar; 273(13):7757-64. PubMed ID: 9516485 [TBL] [Abstract][Full Text] [Related]
54. Merlin/NF2 functions upstream of the nuclear E3 ubiquitin ligase CRL4DCAF1 to suppress oncogenic gene expression. Cooper J; Li W; You L; Schiavon G; Pepe-Caprio A; Zhou L; Ishii R; Giovannini M; Hanemann CO; Long SB; Erdjument-Bromage H; Zhou P; Tempst P; Giancotti FG Sci Signal; 2011 Aug; 4(188):pt6. PubMed ID: 21878678 [TBL] [Abstract][Full Text] [Related]
55. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. James MF; Han S; Polizzano C; Plotkin SR; Manning BD; Stemmer-Rachamimov AO; Gusella JF; Ramesh V Mol Cell Biol; 2009 Aug; 29(15):4250-61. PubMed ID: 19451225 [TBL] [Abstract][Full Text] [Related]
56. Unfurling of the band 4.1, ezrin, radixin, moesin (FERM) domain of the merlin tumor suppressor. Yogesha SD; Sharff AJ; Giovannini M; Bricogne G; Izard T Protein Sci; 2011 Dec; 20(12):2113-20. PubMed ID: 22012890 [TBL] [Abstract][Full Text] [Related]
57. Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin. Laulajainen M; Muranen T; Nyman TA; Carpén O; Grönholm M Neoplasia; 2011 Jul; 13(7):643-52. PubMed ID: 21750658 [TBL] [Abstract][Full Text] [Related]
58. Fluorescence resonance energy transfer analysis of merlin conformational changes. Hennigan RF; Foster LA; Chaiken MF; Mani T; Gomes MM; Herr AB; Ip W Mol Cell Biol; 2010 Jan; 30(1):54-67. PubMed ID: 19884346 [TBL] [Abstract][Full Text] [Related]
59. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Bai Y; Liu YJ; Wang H; Xu Y; Stamenkovic I; Yu Q Oncogene; 2007 Feb; 26(6):836-50. PubMed ID: 16953231 [TBL] [Abstract][Full Text] [Related]
60. Point mutation in the NF2 gene of HEI-193 human schwannoma cells results in the expression of a merlin isoform with attenuated growth suppressive activity. Lepont P; Stickney JT; Foster LA; Meng JJ; Hennigan RF; Ip W Mutat Res; 2008 Jan; 637(1-2):142-51. PubMed ID: 17868749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]